New Jersey legislation · 2026-2027 Regular Session
New Jersey A5737: Pharmacy benf managers & pharmaceutical manuf-conduct audits concerning payments
Status: In committee, October 29, 2026
Requires DOBI to conduct audits concerning payments made to pharmacy benefits managers and affiliates by pharmaceutical manufacturers.
What the bill says
An Act concerning audits of payments made by pharmaceutical manufacturers to pharmacy benefits managers and supplementing P.L.2023, c.107 (C.17B:27F-1 et seq.).
From the introduced text, October 29, 2026:
An Act concerning audits of payments made by pharmaceutical manufacturers to pharmacy benefits managers and supplementing P.L.2023, c.107 (C.17B:27F-1 et seq.). Be It Enacted by the Senate and General Assembly of the State of New Jersey: 1. a. The Department of Banking and Insurance shall conduct audits of all compensation paid to pharmacy benefits managers and affiliates thereof from pharmaceutical manufacturers, with the cost of the audit to be paid by the pharmacy benefits manager being audited. Upon notification from the department of an audit, a pharmacy benefits manager shall have 30 days to provide all documentation requested. The commissioner shall determine the number of audits to be conducted each year and the time period of review for each audit, except that an audit time period shall not exceed one calendar year in duration. b. An audit conducted pursuant to this section shall include, but not be limited to, a review of the following: (1) any compensation provided by a pharmaceutical manufacturer to a pharmacy benefits manager within the timeframe specified; (2) the involvement of any group purchasing organization in the negotiation of compensation between a pharmaceutical manufacturer and a pharmacy benefits manager; and (3) any additional information deemed relevant and appropriate by the commissioner. c. A pharmacy benefits manager that fails to submit the required documentation in a timely …
Sponsors
- Roy Freiman (D, 16) · primary sponsor
Latest actions
- : INT 1RA REF AFI
Subjects: INSURANCE, HEALTH - PHARMACEUTICALS
Common questions
- What is A5737?
- A5737 is a bill in the New Jersey Legislature (2026-2027 Regular Session): Pharmacy benf managers & pharmaceutical manuf-conduct audits concerning payments.
- What does A5737 do?
- In its own words: An Act concerning audits of payments made by pharmaceutical manufacturers to pharmacy benefits managers and supplementing P.L.2023, c.107 (C.17B:27F-1 et seq.).
- What is the status of A5737?
- In committee as of October 29, 2026. Latest action: INT 1RA REF AFI (October 29, 2026).
- Who sponsored A5737?
- Roy Freiman (D, 16).
- Where is the official record for A5737?
- On the New Jersey Legislature website: https://www.njleg.state.nj.us/bill-search/2026/A5737
Source: official New Jersey record. Tracked by Delilah, AI for legislation across all 50 states and Congress.